Trial Profile
A Study to Evaluate the Impact of Teriparatide on Clinical Fractures and Health Related Quality of Life (HRQoL) in Patients With Osteoporosis at High Risk of Rracture
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2020
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms JFOS
- 01 Nov 2017 Status changed from recruiting to completed, according to results published in the Current Medical Research and Opinion.
- 09 Feb 2016 New trial record
- 12 Oct 2015 Interim results presented at the 37th Annual Meeting of the American Society for Bone and Mineral Research.